Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
2006 1
2007 1
2008 2
2009 3
2011 1
2013 2
2014 3
2015 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Drugs: An International Comparison of Postlicensing Price Inflation.
Savage P, Mahmoud S, Patel Y, Kantarjian H. Savage P, et al. J Oncol Pract. 2017 Jun;13(6):e538-e542. doi: 10.1200/JOP.2016.014431. Epub 2017 Feb 7. J Oncol Pract. 2017. PMID: 28605615
PURPOSE: The cost of cancer drugs forms a rising proportion of health care budgets worldwide. A number of studies have examined international comparisons of initial cost, but there is little work on postlicensing price increases. ...In the United Kingdom, the Pharmaceutica …
PURPOSE: The cost of cancer drugs forms a rising proportion of health care budgets worldwide. A number of studies have examined inter …
An approach to the management of leukemia in the developing world.
Chandy M. Chandy M. Clin Lab Haematol. 2006 Jun;28(3):147-53. doi: 10.1111/j.1365-2257.2006.00777.x. Clin Lab Haematol. 2006. PMID: 16706929 Review.
In the developing world where there are significant resource constraints, how does the physician manage leukemia? Government health budgets need to put their money into areas where a small investment is likely to benefit a large proportion of its people and t …
In the developing world where there are significant resource constraints, how does the physician manage leukemia? Government health …
Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST. Rosenberg ST. Dev World Bioeth. 2014 Aug;14(2):83-91. doi: 10.1111/dewb.12050. Epub 2014 Apr 21. Dev World Bioeth. 2014. PMID: 24750542
While pharmaceutical companies have argued that the recognition of patent rights is essential for recovering investments in research and development of pharmaceuticals and incentivizing future innovation, the lack of competition has had damaging consequences for public hea …
While pharmaceutical companies have argued that the recognition of patent rights is essential for recovering investments in research …
Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research.
Rogers J, Carolin T, Vaught J, Compton C. Rogers J, et al. J Natl Cancer Inst Monogr. 2011;2011(42):32-8. doi: 10.1093/jncimonographs/lgr010. J Natl Cancer Inst Monogr. 2011. PMID: 21672893
Investments in medical research and development enable the scientific progress that influences our society's body of knowledge about disease, the quality of health care, and our quality of life. Critical components of these investments include the technological and …
Investments in medical research and development enable the scientific progress that influences our society's body of knowledge about …
Radiation therapy remains the key cost driver of oncology inpatient treatment.
Jakovljevic M, Zugic A, Rankovic A, Dagovic A. Jakovljevic M, et al. J Med Econ. 2015 Jan;18(1):29-36. doi: 10.3111/13696998.2014.971162. Epub 2014 Oct 10. J Med Econ. 2015. PMID: 25268728 Free article.
Total costs of care as well as mean cost per patient were steadily decreasing due to budget cuts caused by global recession. The paradox is that at the same time the budget share of radiotherapy increased for almost 15% and in value-based terms for 109 per patient ( …
Total costs of care as well as mean cost per patient were steadily decreasing due to budget cuts caused by global recession. The para …
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O'Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Patel JD, et al. J Clin Oncol. 2014 Jan 10;32(2):129-60. doi: 10.1200/JCO.2013.53.7076. Epub 2013 Dec 10. J Clin Oncol. 2014. PMID: 24327669
Success requires vision, persistence, and a long-term commitment to supporting cancer research and training. Our nation's longstanding investment in federally funded cancer research has contributed significantly to a growing array of effective new treatments and a much dee …
Success requires vision, persistence, and a long-term commitment to supporting cancer research and training. Our nation's longstanding in …
Trends in research on energy balance supported by the National Cancer Institute.
Ballard-Barbash R, Siddiqi SM, Berrigan DA, Ross SA, Nebeling LC, Dowling EC. Ballard-Barbash R, et al. Am J Prev Med. 2013 Apr;44(4):416-423. doi: 10.1016/j.amepre.2012.11.033. Am J Prev Med. 2013. PMID: 23498109 Free PMC article.
From FY2004 to FY2010, the NCI awarded 269 energy balance-relevant grants totaling $518 million. In FY2010, 4.2% of NCI's total research project grants budget was allocated to energy balance research, compared to 2.1% in FY2004. ...Inclusion of minorities rose, and funding …
From FY2004 to FY2010, the NCI awarded 269 energy balance-relevant grants totaling $518 million. In FY2010, 4.2% of NCI's total research pro …
Why the budget crunch?
Hirshaut Y. Hirshaut Y. Cancer Invest. 1983;1(1):3-4. doi: 10.3109/07357908309040927. Cancer Invest. 1983. PMID: 6667398 No abstract available.
NIH funding trajectories and their correlations with US health dynamics from 1950 to 2004.
Manton KG, Gu XL, Lowrimore G, Ullian A, Tolley HD. Manton KG, et al. Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):10981-6. doi: 10.1073/pnas.0905104106. Epub 2009 Jun 22. Proc Natl Acad Sci U S A. 2009. PMID: 19549852 Free PMC article.
To determine optimal future National Institutes of Health (NIH) funding levels, the longitudinal correlation of the level of investment in NIH research with population changes in the risk of specific diseases should be analyzed. ...
To determine optimal future National Institutes of Health (NIH) funding levels, the longitudinal correlation of the level of investment …
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL, Lichter AS; American Society of Clinical Oncology. Gralow J, et al. J Clin Oncol. 2008 Jan 10;26(2):313-25. doi: 10.1200/JCO.2007.15.4088. Epub 2007 Dec 17. J Clin Oncol. 2008. PMID: 18086794
We are now in the midst of the longest sustained period of flat government funding for cancer research in history. The budgets for the National Institutes of Health and the National Cancer Institute (NCI) have been unchanged for four years. When adjusted for inflati …
We are now in the midst of the longest sustained period of flat government funding for cancer research in history. The budgets …
12 results